The US weed rush and white-collar cannabis CEOs

June 19, 2017

They are bankers, accountants and computer engineers—mainstream in every way but for one respect: their love of cannabis and the desire to make megabucks in a growing US industry.

This week in New York, around 120 people took part in workshops on where and how to invest in cannabis, currently an estimated $7 billion , on the sidelines of the fourth annual World Cannabis Congress.

Mark Giannone and his son Justin, who traveled in from neighboring New Jersey, were among the wannabe cannabis CEOs.

"Both of us love the plant. We want to get involved with the industry, we feel that there is more than just the recreational benefits," explained 31-year-old cybersecurity engineer Justin.

"We came on a fact-finding mission. There is lots of uncertainty," said his 60-year-old accountant father Mark. "I am not quite ready to roll the dice."

Patricia, currently an auditor and unwilling to give her last name because she works for the , is further down the road with her plans—to open a cannabis dispensary this year in Connecticut with her banker husband.

Connecticut, like New Jersey and New York, have legalized the medicinal use of cannabis. But authorities in the two states neighboring the Big Apple have only dispensed a handful of licenses in an industry that is still in its infancy.

Convinced of the virtues of cannabis and users themselves, Mark, Justin and Patricia represent a new wave of professionals wanting to invest in the sector before it is taken over by what Mark calls "Wall Street and the hedge funds."

Like Silicon Valley

Colorado became the first to legalize marijuana for recreational use in 2012. Now, a total of eight US states—including California and Massachusetts—and the federal capital Washington have such expansive laws.

Twenty-nine states and the city of Washington have authorized the use of cannabis for medicinal purposes.

Despite the presence of ultra-conservatives in the Trump administration such as Attorney General Jeff Sessions, these budding entrepreneurs hope the sector will continue its path of rapid growth—projected to reach $23 billion by 2020.

They also hope that in the coming years a majority of states will legalize recreational use, pushing the federal government to review its position and do likewise, following other countries, particularly in Europe.

"We have seen an increasing number of mainstream individuals, from the finance world, large-scale companies from the agricultural world, the science world, very interested in getting involved," said Karson Humiston, CEO of cannabis industry placement agency Vangst who traveled from Denver for the workshop.

"We are receiving 500 resumes a day," said the 24-year-old entrepreneur, comparing the buzz to "being in the Silicon Valley when the tech industry was just taking off."

But one of the speakers, Nichole West, is upfront about the difficulties of making it work in a nascent industry.

A cannabis pioneer, she talks openly about bouncing back from bankruptcy to become, at age 32, vice president of Sweet Leaf, a company of more than 400 people that grows and sells cannabis and offshoot products.

The laws in different states are different and often confusing, creating huge uncertainty for companies, she explains.

- 'Stay away from kids!'

If the proportion of Americans favorable to legalization is growing—a record 61 percent in April according to a poll carried out by CBS News—a significant number still consider cannabis a dangerous drug.

To succeed, you must respect the hostility, West advises.

"Stay away from the kids!" she said. "All it takes is for a mom to get angry at you and then you are the devil!" she tells the class.

"Give money to rehab centers... it's really a good thing because it shows that you are aware drugs are a problem even though cannabis is not," she said.

Lots of her students, all of whom grew up thinking that smoking a joint is no big deal, seem convinced that cannabis going mainstream is only a matter of time.

They also cite latest studies showing benefits for those with certain illnesses, such as epilepsy.

"There is still some stigma, but if you look at the difference between now and five years ago, or 10 years ago when people were totally against it, it has flipped around," says Patricia.

"Once you start educating people, they start changing their minds."

Explore further: More than 500 sign up to buy legal cannabis in Uruguay

Related Stories

More than 500 sign up to buy legal cannabis in Uruguay

May 3, 2017
More than 500 people signed up to buy state-vetted cannabis in Uruguay on the first day of registration for the first such scheme in the world, authorities said Wednesday.

Questions remain about the benefits and harms of cannabis

April 3, 2017
Despite dramatic changes in the legal landscape and usage rates of cannabis, evidence is still lacking regarding its potential health and therapeutic effects. Recently, the National Academies of Sciences, Engineering, and ...

Thousands demand legalisation of cannabis in S.Africa

May 7, 2016
Thousands of South Africans took to the streets of Cape Town on Saturday demanding a relaxation of drugs laws to allow medicinal and recreational use of cannabis.

Germany expects cannabis-growing program to be going in 2019

March 3, 2017
German authorities say they expect to have a cannabis-growing program up and running in 2019 after the country approved legislation allowing some patients to get the drug as a prescription medication.

Medicinal Cannabis—harms or benefits? Who decides?

December 21, 2016
Wellington researchers are calling for doctors to be more involved in the debate around cannabis as a medicine.

Cannabis use in people with epilepsy revealed: Australian survey

March 9, 2017
People with epilepsy resort to cannabis products when antiepileptic drug side-effects are intolerable and epilepsy uncontrolled.

Recommended for you

Postmenopausal women should still steer clear of HRT: task force

December 12, 2017
(HealthDay)—Yet again, the nation's leading authority on preventive medicine says postmenopausal women should avoid hormone replacement therapy (HRT).

Will 'AI' be part of your health-care team?

December 12, 2017
(HealthDay)—Artificial intelligence is assuming a greater role in many walks of life, with research suggesting it may even help doctors diagnose disease.

State-level disclosure laws affect patients' eagerness to have their DNA tested

December 12, 2017
Different types of privacy laws in U.S. states produce markedly different effects on the willingness of patients to have genetic testing done, according to a new study co-authored by an MIT professor.

Babies born during famine have lower cognition in midlife

December 12, 2017
Hunger and malnutrition in infancy may lead to poor cognitive performance in midlife, according to a new study.

Full moon linked to increased risk of fatal motorcycle crashes

December 11, 2017
The full moon is associated with an increased risk of fatal motorcycle crashes in the United States, the United Kingdom, Canada and Australia, finds a study in the Christmas issue of The BMJ.

'Man flu' may be real

December 11, 2017
The much-debated phenomenon of "man flu" may have some basis in fact, suggests an article published in the Christmas issue of The BMJ.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.